Various forms of physical exercise may help prevent diabetes during pregnancy (or gestational diabetes), but data are limited. In a randomized clinical trial published in Acta Obstetricia et Gynecologica Scandinavica including 209 pregnant women, participants who followed a strength training program from gestational weeks 12–14 until week 36 or delivery had lower rates of gestational diabetes.
The incidence of gestational diabetes was 0% in participants who adhered to the strength training program versus 7.3% in the control group, and no cases of large birth weight were recorded in these participants, compared with 6.3% in the control group.
The strength training group showed significant improvements in quality of life and reported lower frequency and impact of pregnancy symptoms. No differences were observed in adverse events, including preterm birth.
“Our findings suggest that adherence to a structured strength training program during pregnancy may help reduce the risk of gestational diabetes while also improving maternal well-being,” said corresponding author Teresa E. Santa Cruz, MD, of Hospital Universitario Donostia, in San Sebastián, Spain. “Further research is needed to confirm these findings and to determine how strength training can best be incorporated into routine prenatal care.”
URL: https://onlinelibrary.wiley.com/doi/10.1111/aogs.70336
Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.
About the Journal
Published monthly, Acta Obstetricia et Gynecologica Scandinavica is an international women's health journal dedicated to providing the very latest information on the results of both clinical and research work from around the globe. The journal regularly publishes commentaries, reviews and original articles on a wide variety of topics, including obstetrics, gynecology, and female urology.
About Wiley
Wiley is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.